Progress and Problems in the Search for an HIV Cure
Program
Integrating HIV Latency
- Anthony S. Fauci, MD
An HIV Cure: Obstacles and Opportunities - Robert F. Siliciano, MD, PhD
Measuring and Clearing the Latent Reservoir for HIV
Immunological/Molecular Basis of Persistence
- Nicolas Chomont, PhD
The Role Of T Cell Homeostasis In HIV Persistence - James I. Mullins, PhD
Host Cell Provirus Integration Sites And Maintenance Of HIV Reservoirs
Early ART
- Katherine F. Ruiz de Luzuriaga, MD
Limiting HIV Persistence And Achieving HIV Cure In Children: Advances And Challenges - Jintanat Ananworanich, MD, PhD
Early ART: A Critical Step In Clinical Trials Towards HIV Remission
Shock and Kill
- Romas Geleziunas, PhD
Therapeutic Strategies Aiming To Achieve ART-Free HIV Remission - Martin Tolstrup, PhD
Clinical Experience With HIV Latency Reversing Agents
Vaccines and Antibodies
- Jeffrey D. Lifson, MD
NHP Models And Therapeutic Vaccination In HIV Cure Research - Dan H. Barouch, MD, PhD
Monoclonal Antibodies For HIV-1 Therapy And Eradication
Gene and Cell Therapy
- Timothy J. Henrich, MD
Stem Cell Transplantation, Cytoreductive Chemotherapy And HIV-1 Persistence - W. David Hardy, MD
A Gene-modified Stem Cell and CD4+ T Cells Approach to Curing HIV/AIDS -the Calimmune Perspective
Downloads
Chair
Warner Greene, MD, PhD
Director, Gladstone Center for HIV Cure Research
Co-Chair
Steven Deeks, MD
Co-Director, Clinical Core
Planning Committee
Mike McCune, MD, PhD
Head, HIV Frontiers Global Health Innovative Technology Solutions Bill & Melinda Gates Foundation
Jeff Sheehy
AIDS Research Institute
Joseph Wong, MD
Associate Director, Virology Core
Contacts
César Cadabes
Community Engagement and Communications Program Analyst